Ikarian Capital’s Lyra Therapeutics LYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $190K | Sell |
21,161
-2
| -0% | -$18 | 0.04% | 84 |
|
|
2025
Q1 | $134K | Hold |
21,163
| – | – | 0.02% | 103 |
|
|
2024
Q4 | $218K | Buy |
21,163
+26
| +0.1% | +$268 | 0.03% | 104 |
|
|
2024
Q3 | $272K | Hold |
21,137
| – | – | 0.04% | 85 |
|
|
2024
Q2 | $292K | Hold |
21,137
| – | – | 0.05% | 77 |
|
|
2024
Q1 | $6.57M | Sell |
21,137
-3,951
| -16% | -$1.23M | 0.72% | 19 |
|
|
2023
Q4 | $6.57M | Hold |
25,088
| – | – | 0.62% | 21 |
|
|
2023
Q3 | $4.9M | Buy |
25,088
+5,515
| +28% | +$1.08M | 0.59% | 18 |
|
|
2023
Q2 | $4.02M | Buy |
19,573
+12,699
| +185% | +$2.61M | 0.64% | 21 |
|
|
2023
Q1 | $711K | Hold |
6,874
| – | – | 0.16% | 64 |
|
|
2022
Q4 | $1.08M | Hold |
6,874
| – | – | 0.26% | 35 |
|
|
2022
Q3 | $1.72M | Sell |
6,874
-73
| -1% | -$18.3K | 0.34% | 31 |
|
|
2022
Q2 | $1.96M | Sell |
6,947
-1,500
| -18% | -$424K | 0.36% | 29 |
|
|
2022
Q1 | $1.7M | Buy |
8,447
+556
| +7% | +$112K | 0.22% | 45 |
|
|
2021
Q4 | $1.72M | Sell |
7,891
-178
| -2% | -$38.8K | 0.26% | 46 |
|
|
2021
Q3 | $3.69M | Sell |
8,069
-4,425
| -35% | -$2.02M | 0.26% | 37 |
|
|
2021
Q2 | $5.02M | Sell |
12,494
-3,121
| -20% | -$1.25M | 0.41% | 33 |
|
|
2021
Q1 | $9.05M | Sell |
15,615
-692
| -4% | -$401K | 0.3% | 20 |
|
|
2020
Q4 | $9.3M | Buy |
16,307
+8,548
| +110% | +$4.87M | 0.41% | 18 |
|
|
2020
Q3 | $4.34M | Buy |
+7,759
| New | +$4.34M | 0.31% | 29 |
|